These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 24935433

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. C3a and C5a promote renal ischemia-reperfusion injury.
    Peng Q, Li K, Smyth LA, Xing G, Wang N, Meader L, Lu B, Sacks SH, Zhou W.
    J Am Soc Nephrol; 2012 Sep; 23(9):1474-85. PubMed ID: 22797180
    [Abstract] [Full Text] [Related]

  • 23. C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage.
    Yuan B, Fu F, Huang S, Lin C, Yang G, Ma K, Shi H, Yang Z.
    Mol Neurobiol; 2017 Oct; 54(8):6187-6197. PubMed ID: 27709492
    [Abstract] [Full Text] [Related]

  • 24. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils.
    de Vries B, Köhl J, Leclercq WK, Wolfs TG, van Bijnen AA, Heeringa P, Buurman WA.
    J Immunol; 2003 Apr 01; 170(7):3883-9. PubMed ID: 12646657
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
    Hsu WC, Yang FC, Lin CH, Hsieh SL, Chen NJ.
    Cell Signal; 2014 Jul 01; 26(7):1409-19. PubMed ID: 24631530
    [Abstract] [Full Text] [Related]

  • 27. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M, Götze O.
    Immunology; 1994 Aug 01; 82(4):516-21. PubMed ID: 7835913
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.
    Wenderfer SE, Ke B, Hollmann TJ, Wetsel RA, Lan HY, Braun MC.
    J Am Soc Nephrol; 2005 Dec 01; 16(12):3572-82. PubMed ID: 16207826
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Expression of C5a and its receptor following spinal cord ischemia reperfusion injury in the rat.
    Dong Q, Sun L, Peng L, Yan B, Lv J, Wang G, Gong S.
    Spinal Cord; 2015 Aug 01; 53(8):581-4. PubMed ID: 25917954
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.
    Hornum L, Hansen AJ, Tornehave D, Fjording MS, Colmenero P, Wätjen IF, Søe Nielsen NH, Bliddal H, Bartels EM.
    PLoS One; 2017 Aug 01; 12(12):e0189017. PubMed ID: 29220376
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
    Atkinson SM, Nansen A, Usher PA, Sondergaard BC, Mackay CR, Friedrichsen B, Chang CC, Tang R, Skov S, Haase C, Hornum L.
    Autoimmunity; 2015 Aug 01; 48(7):460-70. PubMed ID: 25915570
    [Abstract] [Full Text] [Related]

  • 40. Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization.
    Riley RD, Sato H, Zhao ZQ, Thourani VH, Jordan JE, Fernandez AX, Ma XL, Hite DR, Rigel DF, Pellas TC, Peppard J, Bill KA, Lappe RW, Vinten-Johansen J.
    J Thorac Cardiovasc Surg; 2000 Aug 01; 120(2):350-8. PubMed ID: 10917953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.